A Pharmacokinetic Study Comparing SCT400 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma

Clinical trial NCT02456207 · UNKNOWN

Trial details

NCT number: NCT02456207
Sponsor: Sinocelltech Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

B-cell Non Hodgkin's Lymphoma

Start date: 2015-05-01
Primary completion: 2015-12-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.